bioloGPT (BGPT)

bioloGPT — which now operates under the BGPT brand at bgpt.pro — began as a question-answering tool for biology and has grown into what its makers call an evidence layer for scientific AI. Rather than producing a fluent paragraph and leaving you to trust it, the platform returns answers anchored to individual studies, together with novelty or quality scores and explicit statements about each study's scope and limitations. It is aimed at researchers, students, and clinicians who need to see the reasoning and the source, not just the conclusion.

The current product mixes several content types. Paper reviews cover topics from microbiology and immunology to genomics and AI protein design, each summarized with its core claim, the strength of the supporting data, and honest caveats — for example, that a result came from only four patients or that raw data were never deposited publicly. Alongside reviews, the platform publishes experiment designs and health-question explainers that compare what is known against what remains uncertain.

There is also a technical integration angle. The evidence layer is exposed through the Model Context Protocol (MCP), so tools such as Claude and Cursor can query the same evidence base directly, letting AI coding and research assistants ground their outputs in vetted literature rather than model memory alone. This makes bioloGPT less a chatbot you visit and more a data source that other AI workflows plug into. Pricing follows a freemium model, with the public evidence listings browsable for free.